ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Site Inspection Issue Quashes Bristol/C
ScripRedhill Biopharma's RHB-104 For Crohn's Disease RedHill Biopharma Ltd. is in August 2018 expected to report unblinded top-line results from the Phase III MAP US study of RHB-104, an oral antibiotic
ScripThe obesity market has not generated any blockbuster success stories for the biopharmaceutical industry, but Vivus Inc. still sells the prescription weight loss drug Qsymia (phentermine and topira